Covid-19, open science, and the CVD-COVID-UK initiative
- PMID: 33827892
- DOI: 10.1136/bmj.n898
Covid-19, open science, and the CVD-COVID-UK initiative
Conflict of interest statement
Competing interests: JR is the US Outreach and Research Editor at the BMJ. He currently receives research support through Yale University from Johnson & Johnson to develop methods of clinical trial data sharing (support for the YODA project), from the Medical Device Innovation Consortium as part of the National Evaluation System for Health Technology (NEST), from the Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938), from the Agency for Healthcare Research and Quality (R01HS022882), from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) (R01HS025164, R01HL144644), and from the Laura and John Arnold Foundation to establish the Good Pharma Scorecard at Bioethics International. In addition, he is a cofounder of medRxiv, the preprint platform for health sciences research.
Comment on
-
Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource.BMJ. 2021 Apr 7;373:n826. doi: 10.1136/bmj.n826. BMJ. 2021. PMID: 33827854 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical